|
MegaPro Biomedical's Cell Therapy Product MPB‑2354 Selected as Top 8 Finalist in the Healthcare Sector at SelectUSA Tech
|
2026-04-17 |
|
MegaPro Biomedical Announces On‑Track Progress of Global Phase III Clinical Trial Program for MPB‑1523
|
2026-03-16 |
|
MegaPro Biomedical Announces Acceptance of Clinical Study Report for MPB‑1734 Phase 1/2a Trial by Taiwan FDA
|
2026-03-16 |
|
MegaPro Biomedical’s Dual Technology Platforms Enter Value‑Harvesting Phase
|
2026-03-16 |
|
MegaPro Biomedical Announces Submission of Pre‑IND Meeting Request for Phase III Clinical Trial of MPB‑1523
|
2026-03-16 |
